30 days FREE from Class 9 to DropperRegister free

Which of the following statements about recombinant human insulin production is INCORRECT?

BiologyBiotechnology and its Applications · Recombinant DNA Technology in Medicine
  • A. Pro-insulin is an inactive precursor that needs processing to become active insulin
  • B. A and B chains of insulin are produced separately and combined in vitro by disulfide bonds
  • C. The C-peptide connecting A and B chains is retained in the final recombinant insulin product
  • D. Recombinant insulin eliminates the risk of immune reactions associated with animal-derived insulin
Show answer & explanation

Answer: (C) The C-peptide connecting A and B chains is retained in the final recombinant insulin product

Explanation

This statement is incorrect. In recombinant insulin production, the A and B chains are produced separately in E. coli. They are then extracted and combined in vitro, with disulfide bonds forming between them. The C-peptide (connecting peptide of proinsulin) is NOT present in the final active insulin product — it is removed during processing, just as it is in natural insulin maturation.

Practise every Biotechnology and its Applications question with a timer

Chapter tests, full NEET mocks, your score and weak topics — 70,000+ questions on YNeet.

Start free for 30 days

No payment, no card. Sign up in 30 seconds.

For Class 11, 12 and droppers, see what the YNeet NEET online course includes.

More Biotechnology and its Applications questions

All free Biotechnology and its Applications PYQs →